Target Corporation logo

Target Corporation (TGT)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
154. 26
-2.37
-1.5131%
$
69.03B Market Cap
17.63 P/E Ratio
23.53% Div Yield
6.2M Volume
5.54 Eps
$ 156.63
Previous Close
Add Transaction
Day Range
153.39 159.56
Year Range
83.44 170.75
Want to track TGT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bernstein Lifts American Tower to Outperform With $207 Price Target. Time to Buy the Tower REITs?

Bernstein Lifts American Tower to Outperform With $207 Price Target. Time to Buy the Tower REITs?

Tower REITs picked up a fresh vote of confidence from Wall Street this morning. American Tower (NYSE:AMT | AMT Price Prediction) was upgraded by Bernstein to Outperform with a $207 price target, sending shares of the wireless infrastructure giant higher in early trading.

247wallst | 5 months ago
Target Plans to Name a New Supply-Chain Head as It Struggles With Weak Sales

Target Plans to Name a New Supply-Chain Head as It Struggles With Weak Sales

Former Walmart executive Jeff England will lead supply chain and logistics at the retailer as Target tries to pull out of a yearslong sales slump.

Wsj | 5 months ago
Target to Report Q1 Earnings: Is Another Beat in the Cards?

Target to Report Q1 Earnings: Is Another Beat in the Cards?

TGT reports Q1 FY26 on May 20; beauty, essentials and same-day drive momentum as discretionary softness and costs test margins.

Zacks | 5 months ago
Citi Raises Coca-Cola Price Target to $91: World Cup Could Pour Volumes Higher

Citi Raises Coca-Cola Price Target to $91: World Cup Could Pour Volumes Higher

Citi just nudged its target on Coca-Cola (NYSE:KO | KO Price Prediction) higher, taking the price target to $91 from $90 while reiterating a Buy rating.

247wallst | 5 months ago
This Is How Much Target Stock Is Expected to Move After Earnings

This Is How Much Target Stock Is Expected to Move After Earnings

Target is scheduled to report earnings ahead of the opening bell Wednesday, with the retailer's stock seen potentially testing its highest point in over a year following the results.

Investopedia | 5 months ago
JPMorgan Cuts Advance Auto Parts Price Target as Tax Stimulus Fights Energy Price Headwinds

JPMorgan Cuts Advance Auto Parts Price Target as Tax Stimulus Fights Energy Price Headwinds

JPMorgan analyst Christopher Horvers trimmed his price target on Advance Auto Parts (NYSE:AAP | AAP Price Prediction) to $59 from $64 on May 15, keeping a Neutral rating.

247wallst | 5 months ago
Canaccord Just Hiked Intuitive Machines Price Target to $41: NASA Moon Base, Golden Dome Power Bull Case

Canaccord Just Hiked Intuitive Machines Price Target to $41: NASA Moon Base, Golden Dome Power Bull Case

A major analyst just made the bull case for Intuitive Machines (NASDAQ:LUNR).

247wallst | 5 months ago
Citi Cuts Lucid Price Target to $14: Q1 Miss, Pulled Guidance Test the Saudi-Backed EV Maker

Citi Cuts Lucid Price Target to $14: Q1 Miss, Pulled Guidance Test the Saudi-Backed EV Maker

Citi just trimmed its price target on Lucid Group (NASDAQ:LCID | LCID Price Prediction) to $14 from $17, while keeping a Buy rating.

247wallst | 5 months ago
JPMorgan Hikes Dell Price Target to $280: Memory Concerns Fade as AI Server Story Powers On

JPMorgan Hikes Dell Price Target to $280: Memory Concerns Fade as AI Server Story Powers On

Dell Technologies (NYSE:DELL | DELL Price Prediction) just got another bullish nod from Wall Street.

247wallst | 5 months ago
Countdown to Target (TGT) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to Target (TGT) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Target (TGT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2026.

Zacks | 5 months ago
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6

Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin glioblastoma story.

247wallst | 5 months ago
Jefferies Hikes Palo Alto Networks Price Target to $265: AI Is Compressing Attack Timelines

Jefferies Hikes Palo Alto Networks Price Target to $265: AI Is Compressing Attack Timelines

Jefferies analyst Joseph Gallo raised his price target on Palo Alto Networks (NASDAQ:PANW | PANW Price Prediction) to $265 from $215, reiterating a Buy rating following CyberArk's IMPACT26 Conference.

247wallst | 5 months ago
Loading...
Load More